Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06416059 · ClinicalTrials.gov registry record · NA
A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking
A NA study of Anxiety and Alcohol Abuse, sponsored by University of Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06416059: Recruiting NA study of Anxiety and Alcohol Abuse, sponsored by University of Houston.
NCT06416059 is a NA study of Anxiety and Alcohol Abuse that is actively recruiting participants, run by University of Houston. The registered enrollment target is 50 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06416059, a NA study of Anxiety and Alcohol Abuse, is actively recruiting participants, sponsored by University of Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Black hazardous drinkers with clinical anxiety.
Conditions Studied
Interventions
- BEHAVIORAL Mobile Application
Study Locations (1)
Texas
- RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
What NCT06416059 shows while recruiting
NCT06416059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Mobile Application is the first listed.
NCT06416059 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06416059 about?
NCT06416059 is a clinical study titled "A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking". The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation an...
What is the current status of trial NCT06416059?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-05-15. Estimated completion is 2024-08-31.
What conditions does trial NCT06416059 study?
This clinical trial studies the following conditions: Anxiety, Alcohol Abuse.
What interventions are being tested in trial NCT06416059?
The interventions under investigation include: Mobile Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT06416059?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06416059 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06416059's enrollment target sits among peer trials
50 246th of 364 higher than 110 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI